HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$32.21
Day range
$31.26 - $33.21
Year range
$12.57 - $40.40
Market cap
1.20B USD
Avg Volume
541.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 13.08M | 30.76% |
Operating expense | 43.00M | 193.89% |
Net income | -41.90M | -208.13% |
Net profit margin | -320.45 | -135.64% |
Earnings per share | -1.31 | -162.42% |
EBITDA | -44.10M | -194.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 227.44M | 4.80% |
Total assets | 265.49M | 16.51% |
Total liabilities | 68.50M | 95.93% |
Total equity | 196.99M | — |
Shares outstanding | 34.22M | — |
Price to book | 5.59 | — |
Return on assets | -41.63% | — |
Return on capital | -46.87% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -41.90M | -208.13% |
Cash from operations | -39.34M | -261.73% |
Cash from investing | 17.85M | 120.47% |
Cash from financing | 19.76M | 7,384.85% |
Net change in cash | -1.72M | 98.24% |
Free cash flow | -25.04M | -320.09% |
About
Founded
2016
Headquarters
Website
Employees
244